Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Sep;70(3):405–408. doi: 10.1038/bjc.1994.318

In vitro reactivity and in vivo biodistribution of the monoclonal antibody A7 using human gastric carcinoma cell lines.

N Yamaoka 1, T Yamaguchi 1, E Otsuji 1, M Kato 1, T Kotani 1, K Kitamura 1, T Takahashi 1
PMCID: PMC2033351  PMID: 8080722

Abstract

The monoclonal antibody (MAb) A7 has been used to treat patients with colorectal or pancreatic carcinoma with encouraging results. We therefore determined if MAb A7 would also react with gastric carcinoma cell lines. MAb A7 reacted with seven of eight gastric carcinoma cell lines tested. The intensity of the reaction, measured by flow cytometry, was equal to that of WiDr (colon) and HPC-YS (pancreas) cell lines. In nude mice bearing xenografts of the MAb A7-reactive gastric cancer line MKN45, the percentage injected dose of MAb A7 per g of tumour tissue on day 7 was 9.79; this value was 77% of that on day 1. The in vivo tumour-to-blood ratio of MAb A7 was 2.77 on day 7. Therefore, MAb A7 has long-term retention at binding sites as well as a high probability, high intensity and high specificity of reactivity against gastric cancer, which make it an ideal drug carrier for immunotargeted chemotherapy and immunodiagnosis.

Full text

PDF
405

Images in this article

406Figure 2
on p.406

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdel-Nabi H. H., Schwartz A. N., Wechter D. G., Higano C. S., Ortman-Nabi J. A., Unger M. W. Scintigraphic detection of gastric and pancreatic carcinomas with In-111 ZCE 025 monoclonal antibody. World J Surg. 1991 Jan-Feb;15(1):122–127. doi: 10.1007/BF01658982. [DOI] [PubMed] [Google Scholar]
  2. Boeckmann W., Baum R. P., Schuldes H., Kramer W., Hertel A., Baew-Christow T., Hanke P., Jonas D., Hör G. Tumour imaging of bladder carcinomas and their metastases with 111indium-labelled monoclonal anti-CEA antibody BW 431/26. Br J Cancer Suppl. 1990 Jul;10:81–84. [PMC free article] [PubMed] [Google Scholar]
  3. Bollschweiler E., Boettcher K., Hoelscher A. H., Sasako M., Kinoshita T., Maruyama K., Siewert J. R. Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer. 1993 May 15;71(10):2918–2925. doi: 10.1002/1097-0142(19930515)71:10<2918::aid-cncr2820711006>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  4. Frödin J. E., Lefvert A. K., Mellstedt H. Pharmacokinetics of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedules. Cancer Res. 1990 Aug 15;50(16):4866–4871. [PubMed] [Google Scholar]
  5. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  6. Inoue K., Tobe T., Kan N., Nio Y., Sakai M., Takeuchi E., Sugiyama T. Problems in the definition and treatment of early gastric cancer. Br J Surg. 1991 Jul;78(7):818–821. doi: 10.1002/bjs.1800780717. [DOI] [PubMed] [Google Scholar]
  7. Kitamura K., Takahashi T., Yamaguchi T., Yokota T., Noguchi A., Amagai T., Imanishi J. Immunochemical characterization of the antigen recognized by the murine monoclonal antibody A7 against human colorectal cancer. Tohoku J Exp Med. 1989 Feb;157(2):83–93. doi: 10.1620/tjem.157.83. [DOI] [PubMed] [Google Scholar]
  8. Kotanagi H., Takahashi T., Masuko T., Hashimoto Y., Koyama K. A monoclonal antibody against human colon cancers. Tohoku J Exp Med. 1986 Apr;148(4):353–360. doi: 10.1620/tjem.148.353. [DOI] [PubMed] [Google Scholar]
  9. Moriguchi S., Odaka T., Hayashi Y., Nose Y., Maehara Y., Korenaga D., Sugimachi K. Death due to recurrence following curative resection of early gastric cancer depends on age of the patient. Br J Cancer. 1991 Sep;64(3):555–558. doi: 10.1038/bjc.1991.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Otsuji E., Takahashi T., Yamaguchi T., Yamaguchi N., Imanishi J. Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma. Gastroenterol Jpn. 1990 Apr;25(2):244–248. doi: 10.1007/BF02776823. [DOI] [PubMed] [Google Scholar]
  11. Otsuji E., Yamaguchi T., Yamaoka N., Yamaguchi N., Imanishi J., Takahashi T. Biodistribution of monoclonal antibody A7 and its F(ab')2 fragment in athymic nude mice bearing human pancreatic carcinoma. J Surg Oncol. 1992 Jul;50(3):173–178. doi: 10.1002/jso.2930500309. [DOI] [PubMed] [Google Scholar]
  12. Reintgen D. S., Shimizu K., Coleman E., Briner W., Kitzmiller J., Eisenbarth G., Seigler H. F. Immunodiagnosis of tumors in vivo using radiolabeled monoclonal antibody A2B5. J Surg Oncol. 1983 Jul;23(3):205–211. doi: 10.1002/jso.2930230318. [DOI] [PubMed] [Google Scholar]
  13. Sickle-Santanello B. J., O'Dwyer P. J., Mojzisik C., Tuttle S. E., Hinkle G. H., Rousseau M., Schlom J., Colcher D., Thurston M. O., Nieroda C. Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors. Dis Colon Rectum. 1987 Oct;30(10):761–764. doi: 10.1007/BF02554623. [DOI] [PubMed] [Google Scholar]
  14. Takahashi T., Yamaguchi T., Kitamura K., Noguchi A., Honda M., Otsuji E. Follow-up study of patients treated with monoclonal antibody-drug conjugate: report of 77 cases with colorectal cancer. Jpn J Cancer Res. 1993 Sep;84(9):976–981. doi: 10.1111/j.1349-7006.1993.tb00188.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Takahashi T., Yamaguchi T., Kitamura K., Suzuyama H., Honda M., Yokota T., Kotanagi H., Takahashi M., Hashimoto Y. Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma. Cancer. 1988 Mar 1;61(5):881–888. doi: 10.1002/1097-0142(19880301)61:5<881::aid-cncr2820610505>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  16. Tjandra J. J., Pietersz G. A., Teh J. G., Cuthbertson A. M., Sullivan J. R., Penfold C., McKenzie I. F., Smyth M. Phase I clinical trial of drug-monoclonal antibody conjugates in patients with advanced colorectal carcinoma: a preliminary report. Surgery. 1989 Sep;106(3):533–545. [PubMed] [Google Scholar]
  17. Tominaga S. Decreasing trend of stomach cancer in Japan. Jpn J Cancer Res. 1987 Jan;78(1):1–10. [PubMed] [Google Scholar]
  18. Tsuda T., Koshiba H., Usui T., Kubota M., Kikuchi K., Morita K. Radioimmunoscintigraphy of human pancreatic carcinoma xenografts in nude mice with 131I-labeled monoclonal antibody. Ann Nucl Med. 1990 Jul;4(2):71–74. doi: 10.1007/BF03164599. [DOI] [PubMed] [Google Scholar]
  19. Yamaguchi N., Yamamura Y., Koyama K., Ohtsuji E., Imanishi J., Ashihara T. Characterization of new human pancreatic cancer cell lines which propagate in a protein-free chemically defined medium. Cancer Res. 1990 Nov 1;50(21):7008–7014. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES